|
|
||||||||
Departments of 1 Physiology and 2 Anesthesiology, Mie University School of Medicine, 514-8507 Mie, Japan
We determined the role of an endothelium-derived
contracting factor in the impaired relaxation response to ACh of
conduit pulmonary arteries (PAs) isolated from rats with hypoxic
pulmonary hypertension (PH). A
PGH2/thromboxane
A2
(TxA2)-receptor antagonist (ONO-3708) partially restored the impairment of ACh-induced relaxation, whereas TxA2 synthase inhibitors
(OKY-046 and CV-4151) did not affect the impaired relaxation in
phenylephrine-precontracted hypertensive PAs. Endothelium-denuded
hypertensive PA rings showed no difference in the response to ACh
between preparations with and without ONO-3708. In both
endothelium-denuded control and hypertensive PAs, exogenous
PGH2 induced contractions, and the magnitude of the contractions was greater in the control than in
hypoxic PH preparations. An endothelin A-receptor antagonist (BQ-485),
an endothelin B-receptor antagonist (BQ-788), and a superoxide anion
scavenger (superoxide dismutase) did not restore the impaired response
to ACh in hypertensive PAs. These findings suggest that
PGH2 produced from the conduit PAs
of rats with chronic hypoxic PH may be the endothelium-derived
contracting factor responsible for the impairment of ACh-mediated vasorelaxation.
chronic hypoxia; prostaglandin H2; thromboxane A2; nitric oxide
This article has been cited by other articles:
![]() |
Y. Sawada, K. Onoda, K. Imanaka-Yoshida, J. Maruyama, K. Yamamoto, T. Yoshida, and H. Shimpo Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis Cardiovasc Res, June 1, 2007; 74(3): 366 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Fike, Y. Zhang, and M. R. Kaplowitz Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets J Appl Physiol, August 1, 2005; 99(2): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Maruyama, B. H. Jiang, K. Maruyama, M. Takata, and K. Miyasaka Prolonged Nitric Oxide Inhalation During Recovery From Chronic Hypoxia Does Not Decrease Nitric Oxide-Dependent Relaxation in Pulmonary Arteries Chest, December 1, 2004; 126(6): 1919 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yuda, Y. Adachi, O. Taguchi, E. C. Gabazza, O. Hataji, H. Fujimoto, S. Tamaki, K. Nishikubo, K. Fukudome, C. N. D'Alessandro-Gabazza, et al. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice Blood, March 15, 2004; 103(6): 2196 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chu, C. C. Sullivan, L. Du, A. J. Cho, M. Kido, P. L. Wolf, M. D. Weitzman, S. W. Jamieson, and P. A. Thistlethwaite A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1 Ann. Thorac. Surg., February 1, 2004; 77(2): 449 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Fike, S. L. Pfister, M. R. Kaplowitz, and J. A. Madden Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs J Appl Physiol, January 1, 2002; 92(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Davidge Prostaglandin H Synthase and Vascular Function Circ. Res., October 12, 2001; 89(8): 650 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |